Citicoline as Neuroprotector in Neonates Exposed to Hypoxia
ConditionNeonatal Hypoxia
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
AgeUp to 1
SponsorSherief Abd-Elsalam
About this trial
Citicoline as neuroprotector in neonates exposed to hypoxia: A randomized controlled trial
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
neonates with hypoxia.
Disqualifiers
hypoxic ischemic encephalopathy
Trial design
Design model
Parallel
Treatments tested in this trial
Citicoline
DrugCitacoline as neuroprotector
Placebo
Other interventionplacebo group
Treatment groups
40 Participants
are divided into 2 treatment groupsGroup A: CitacolineExperimental treatment 1 intervention
Group B: PlaceboPlacebo comparator 1 intervention
Trial outcomes
Primary outcomes
1
number of seizures
Time frame
6 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Sherief Abd-Elsalam
Lead sponsor
Tanta University
Sponsor institution
Source ClinicalTrials.gov